Huilin Tang

机构：California University of Pennsylvania, Science History Institute, Nanning Normal University, City University of Macau, University of Pennsylvania, Philadelphia University · ORCID：0000-0002-5814-6657

发表论文 179 篇 · 总被引 4618 次 · h-index 39

代表论文

• Efficacy and Safety of GLP-1 RAs in Children and Adolescents With Obesity or Type 2 Diabetes (2025 · Archives of Pediatrics and Adolescent Medicine · 被引 32)
• Cardiovascular and kidney outcomes of GLP ‐1 receptor agonists in adults with obesity: A target trial emulation study (2025 · Diabetes Obesity and Metabolism · 被引 15)
• Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes (2025 · Obesity · 被引 12)
• GLP ‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation (2025 · Obesity · 被引 11)
• Real-world comparative outcomes of GLP-1 RA and semaglutide prescription among individuals with type 2 diabetes (2025 · medRxiv · 被引 4)
• Post-Acute Dyslipidemia and Abnormal Body Mass Index in Children and Adolescents with COVID-19: A Cohort Study from the RECOVER Initiative (2026 · The Journal of Pediatrics · 被引 2)